GHK-Cu + KPV: The Blend Needs Its Own Evidence
AXON Research Institute • AXON Peptide affiliation
Educational draft • Scientific + legal review pending
Silent film with full on-screen captions. Conceptual illustrations, not molecular structures.

A label combining GHK-Cu and KPV raises two separate questions: what is actually in the mixture, and what evidence applies to that finished formulation? The ingredient amounts, chemical forms, formulation and batch identity have not been independently verified here. A product name cannot substitute for those details. Research on an individual ingredient does not automatically establish a mixture's safety or benefit. Ingredients can interact, and delivery can change the relevant exposure. Official evidence guidance emphasizes matching research to the actual product. Until the mixture and supporting studies are verified, combination-benefit claims remain unsupported by this review.

END CARD
Educational draft. Not medical advice. Sources and limitations accompany this film.

SOURCES
[1] FDA: Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q7a-good-manufacturing-practice-guidance-active-pharmaceutical-ingredients
Official manufacturing and identity-control guidance

[2] Federal Trade Commission: Health Products Compliance Guidance, product-specific evidence and combination examples
https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
Official scientific-substantiation guidance

EVIDENCE LIMITATIONS
The catalog contains an indexed seller label, not a verified composition or batch analysis.
No dedicated efficacy claim is made for GHK-Cu plus KPV.
This limited review does not assert that no combination study exists anywhere; it states that supporting evidence has not been established here.

TOPIC INVENTORY PROVENANCE (not reused audiovisual media)
GHK-Cu Plus KPV: Verify the Mixture Before Interpreting Its Evidence